Nitrous oxide for glycine encephalopathy
David A. August,
Hung G. Nguyen,
David A. August
Department of Anesthesiology and Pain Medicine, University of California Davis Medical Center, Sacramento, CA, USA(email: [email protected] )
Search for more papers by this authorHung G. Nguyen
Department of Anesthesiology and Pain Medicine, University of California Davis Medical Center, Sacramento, CA, USA(email: [email protected] )
Search for more papers by this authorDavid A. August,
Hung G. Nguyen,
David A. August
Department of Anesthesiology and Pain Medicine, University of California Davis Medical Center, Sacramento, CA, USA(email: [email protected] )
Search for more papers by this authorHung G. Nguyen
Department of Anesthesiology and Pain Medicine, University of California Davis Medical Center, Sacramento, CA, USA(email: [email protected] )
Search for more papers by this author
References
- 1 Baum VC, O’Flaherty JE. Anesthesia for Genetic, Metabolic, and Dysmorphic Syndromes of Childhood. 2nd edn. Philadelphia: Lippincott Williams & Wilkins 2007: 272–273.
- 2 Van Hove JLK, Kishnani P, Muenzer J et al. Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia. Am J Med Gen 1995; 59: 444–453.
- 3 Van Hove JLK, Kishnani PS, Demaerel P et al. Acute hydrocephalus in nonketotic hyperglycinemia. Neurology 2000; 54(3): 754–756.
- 4 Kilb W, Hanganu IL, Okabe A et al. Glycine receptors mediate excitation of subplate neurons in neonatal rat cerebral cortex. J Neurophysiol 2008; 100: 698–707.
- 5 Celine J-X, Mentis GZ, O’Donovan MJ et al. Dual personality of GABA/glycine-mediated depolarizations in immature spinal cord. PNAS 2007; 104(27): 11477–11482.
- 6 Deutsch SI, Rosse RB, Mastropaolo J. Current status of NMDA antagonist interventions in the treatment of nonketotic hyperglycinemia. Clin Neuropharm 1998; 21(2): 71–79.
- 7 Barker C, Jefferson P, Ball DR. Glycine encephalopathy and anesthesia. Anesth Analg 2007; 105(2): 544.
- 8 Hamoush A, McDonald JW, Valle D et al. Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant. J Pediatr 1992; 121(1): 131–135.
- 9 Liu C-M, Fan S-Z. Glycine encephalopathy and delayed emergence from anesthesia. Anesth Analg 2006; 103(6): 1630.
- 10 Sami KA. Non-ketotic hyperglycinaemias. Can Anaesth Soc J 1980; 27: 79–80.
- 11 Jevtovic-Todorovic V, Todorovic SM, Mennerick S et al. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nature Med 1998; 4(4): 460–463.
Citing Literature
